ASCJ 9

Drug Profile

ASCJ 9

Alternative Names: ASC-J9; Dimethyl curcumin

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AndroScience Corporation
  • Class Alkadienes; Antiacnes; Catechols; Small molecules
  • Mechanism of Action Androgen receptor degradation enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Acne vulgaris
  • No development reported Male pattern baldness; Spinal muscular atrophy; Wounds

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Male-pattern-baldness in USA (Topical, Foam)
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Spinal-muscular-atrophy in USA (PO)
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Wounds in USA (Topical, Cream)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top